Stocktoria
ACADIA PHARMACEUTICALS INC ACAD
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2004-05-27
ACADIA PHARMACEUTICALS INC financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $1.1B | $957.8M | $726.4M | $517.2M | $484.1M |
| Gross profit | — | — | $684.8M | $507.1M | $473.3M |
| R&D expense | $328.8M | $303.2M | $351.6M | $361.6M | $239.4M |
| SG&A expense | $548.9M | $488.4M | $406.6M | $369.1M | $396.0M |
| Operating income | $104.8M | $230.8M | -$73.4M | -$223.6M | -$170.4M |
| Income tax | -$252.1M | $31.6M | $10.2M | $2.5M | $351,000 |
| Net income | $391.0M | $226.5M | -$61.3M | -$216.0M | -$167.9M |
| EPS (diluted) | $2.30 | $1.36 | $-0.37 | $-1.34 | $-1.05 |
| Operating cash flow | $109.8M | $157.7M | $16.7M | -$114.0M | -$125.7M |
| Free cash flow | $105.1M | $157.2M | $16.7M | -$114.0M | -$126.8M |
| Cash & equivalents | $177.7M | $319.6M | $188.7M | $114.8M | $147.4M |
| Inventory | $111.4M | $91.7M | $40.4M | $11.6M | $14.1M |
| Total assets | $1.6B | $1.2B | $749.0M | $587.8M | $700.1M |
| Total liabilities | $336.8M | $455.0M | $317.2M | $187.4M | $159.2M |
| Shareholders' equity | $1.2B | $732.8M | $431.8M | $400.4M | $540.9M |
Source: SEC EDGAR filings · CIK 0001070494 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.